• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子、其受体和转化生长因子-β1 在 HCV 诱导的肝细胞癌诊断中的作用。

Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma.

机构信息

Oncology Diagnostic Unit, Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Med Oncol. 2013;30(3):673. doi: 10.1007/s12032-013-0673-x. Epub 2013 Aug 3.

DOI:10.1007/s12032-013-0673-x
PMID:23912699
Abstract

In this article, we present a study on the levels of epidermal growth factor (EGF), its phosphorylated receptor (p-EGFR) and transforming growth factor-β1 (TGF-β1) in the sera of patients with hepatocellular carcinoma (HCC) and chronic hepatitis C (CHC) infection. The results reveal significant higher serum levels of EGF and TGF-β1 in patients with HCC compared to their level in patients with CHC infection and control subjects. The levels of p-EGFR in HCC and CHC patients show a highly significant difference between patients. Based on the best cutoff value of 914 pg/ml, EGF shows 63.3 % sensitivity and 87.5 % specificity for HCC patients where the area under the curve is 0.81. The p-EGFR shows sensitivity of 63.3 % and specificity of 100 % where the area under the curve is 0.87 for HCC patients based on the best cutoff value of 39 U/mg protein. The best cutoff value (370 pg/ml) for serum TGF-β1 displays sensitivity of 86.7 % and specificity of 100 %, where the area under the curve is 0.97 for HCC patients.

摘要

在本文中,我们研究了表皮生长因子(EGF)、其磷酸化受体(p-EGFR)和转化生长因子-β1(TGF-β1)在肝细胞癌(HCC)和慢性丙型肝炎(CHC)感染患者血清中的水平。结果显示,与 CHC 感染患者和对照组相比,HCC 患者的血清 EGF 和 TGF-β1 水平显著升高。HCC 和 CHC 患者的 p-EGFR 水平在患者之间存在显著差异。基于最佳截断值 914 pg/ml,EGF 对 HCC 患者的敏感性为 63.3%,特异性为 87.5%,曲线下面积为 0.81。p-EGFR 对 HCC 患者的敏感性为 63.3%,特异性为 100%,基于最佳截断值 39 U/mg 蛋白,曲线下面积为 0.87。血清 TGF-β1 的最佳截断值(370 pg/ml)对 HCC 患者的敏感性为 86.7%,特异性为 100%,曲线下面积为 0.97。

相似文献

1
Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma.表皮生长因子、其受体和转化生长因子-β1 在 HCV 诱导的肝细胞癌诊断中的作用。
Med Oncol. 2013;30(3):673. doi: 10.1007/s12032-013-0673-x. Epub 2013 Aug 3.
2
TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.埃及丙型肝炎病毒相关慢性肝病和肝细胞癌患者中的转化生长因子-β1和C-erb-B2神经癌蛋白
Egypt J Immunol. 2008;15(1):39-50.
3
Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.血浆转化生长因子-β1及循环转化生长因子-β1信使核糖核酸在肝细胞癌诊断中的临床意义
Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):288-95.
4
The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.慢性丙型肝炎、肝硬化和肝细胞癌患者的Bcl-2和转化生长因子-β1水平。
Egypt J Immunol. 2004;11(1):83-90.
5
Transforming Growth Factor-β1 as a Predictor for the Development of Hepatocellular Carcinoma: A Nested Case-Controlled Study.转化生长因子-β1 作为肝细胞癌发展的预测因子:一项巢式病例对照研究。
EBioMedicine. 2016 Oct;12:68-71. doi: 10.1016/j.ebiom.2016.09.001. Epub 2016 Sep 2.
6
Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.表皮生长因子基因遗传多态性作为丙型肝炎肝硬化患者肝细胞癌的预测指标。
Asian Pac J Cancer Prev. 2020 Jul 1;21(7):2047-2053. doi: 10.31557/APJCP.2020.21.7.2047.
7
Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesis.循环转化生长因子-β和表皮生长因子受体与肝癌发生中的病毒感染有关。
Anticancer Res. 2012 Jan;32(1):141-5.
8
Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.埃及患者中用于早期检测丙型肝炎病毒感染相关肝细胞癌的血清生物标志物
Asian Pac J Cancer Prev. 2015;16(3):1281-7. doi: 10.7314/apjcp.2015.16.3.1281.
9
Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.转化生长因子-β1基因在肝细胞癌中的表达:初步报告。
Arab J Gastroenterol. 2014 Sep-Dec;15(3-4):142-7. doi: 10.1016/j.ajg.2014.10.007. Epub 2014 Dec 2.
10
Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.表皮生长因子受体和转化生长因子-α对丙型肝炎病毒诱导的肝癌发生的影响。
APMIS. 2015 Oct;123(10):823-31. doi: 10.1111/apm.12431. Epub 2015 Aug 17.

引用本文的文献

1
The Impact of Liver Steatosis on Interleukin and Growth Factors Kinetics during Chronic Hepatitis C Treatment.肝脂肪变性对慢性丙型肝炎治疗期间白细胞介素和生长因子动力学的影响。
J Clin Med. 2024 Aug 16;13(16):4849. doi: 10.3390/jcm13164849.
2
Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection.用于癌症生物标志物检测的表面等离子体共振 (SPR) 传感器。
Biosensors (Basel). 2023 Mar 17;13(3):396. doi: 10.3390/bios13030396.
3
The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD.

本文引用的文献

1
Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.肝细胞癌:肿瘤发生与预测标志物
Gastroenterology Res. 2009 Aug;2(4):191-199. doi: 10.4021/gr2009.07.1304. Epub 2009 Jul 20.
2
Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.表皮生长因子受体(EGFR)在肝癌中的相互作用。
Cancers (Basel). 2011 May 18;3(2):2444-61. doi: 10.3390/cancers3022444.
3
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.HBV 和 HCV 相关肝细胞癌的发病机制。
干细胞因子、表皮生长因子和血管生成素-2在乙肝病毒、丙肝病毒、肝癌和非酒精性脂肪性肝病中的作用
Life (Basel). 2022 Dec 9;12(12):2072. doi: 10.3390/life12122072.
4
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma.解析转化生长因子-β 1 在肝细胞癌诊断、预后和治疗中的作用。
World J Gastroenterol. 2022 Sep 28;28(36):5250-5264. doi: 10.3748/wjg.v28.i36.5250.
5
Inverse relationship between the level of miRNA 148a-3p and both TGF-β1 and FIB-4 in hepatocellular carcinoma.肝细胞癌中miRNA 148a - 3p水平与TGF-β1和FIB - 4之间的负相关关系。
Biochem Biophys Rep. 2021 Jul 20;27:101082. doi: 10.1016/j.bbrep.2021.101082. eCollection 2021 Sep.
6
Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).肝细胞癌新型诊断生物标志物的准确性:临床医生最新进展(综述)
Oncol Rep. 2016 Aug;36(2):613-25. doi: 10.3892/or.2016.4842. Epub 2016 Jun 1.
7
EGFR Signaling in Liver Diseases.肝脏疾病中的表皮生长因子受体信号传导
Int J Mol Sci. 2015 Dec 29;17(1):30. doi: 10.3390/ijms17010030.
Nat Rev Cancer. 2013 Feb;13(2):123-35. doi: 10.1038/nrc3449.
4
Molecular classification of hepatocellular carcinoma anno 2011.2011 年肝细胞癌的分子分类。
Eur J Cancer. 2011 Aug;47(12):1789-97. doi: 10.1016/j.ejca.2011.04.027. Epub 2011 May 24.
5
Hepatocellular carcinoma: A global view.肝细胞癌:全球视角。
Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58. doi: 10.1038/nrgastro.2010.100. Epub 2010 Jul 13.
6
Association between hepatitis C and hepatocellular carcinoma.丙型肝炎与肝细胞癌之间的关联。
J Glob Infect Dis. 2009 Jan;1(1):33-7. doi: 10.4103/0974-777X.52979.
7
Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.表皮生长因子 61A/G 多态性与中国患者肝细胞癌易感性的关系。
Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x. Epub 2009 Oct 15.
8
Diagnosis of hepatocellular carcinoma.肝细胞癌的诊断
World J Gastroenterol. 2009 Mar 21;15(11):1301-14. doi: 10.3748/wjg.15.1301.
9
Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.肝细胞癌是通过异常血管生成,由转化生长因子β信号转导衔接蛋白胚胎肝肌动蛋白缺失所致。
Hepatology. 2008 Oct;48(4):1128-37. doi: 10.1002/hep.22460.
10
Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.血浆转化生长因子-β1及循环转化生长因子-β1信使核糖核酸在肝细胞癌诊断中的临床意义
Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):288-95.